Cited by 1,215Frailty in Older AdultsChronic Disease Management StrategiesPharmaceutical Practices and Patient Outcomes

Phenotype of frailty: characterization in the women's health and aging studies

Bandeen-Roche, K., Xue, Q.-L., Ferrucci, L., Walston, J., Guralnik, J. M., Chaves, P., Zeger, S. L., Fried, L. P.·2006·The Journals of Gerontology Series A: Biological Sciences and Medical Sciences

Abstract

BACKGROUND: "Frailty" is an adverse, primarily gerontologic, health condition regarded as frequent with aging and having severe consequences. Although clinicians claim that the extremes of frailty can be easily recognized, a standardized definition of frailty has proved elusive until recently. This article evaluates the cross-validity, criterion validity, and internal validity in the Women's Health and Aging Studies (WHAS) of a discrete measure of frailty recently validated in the Cardiovascular Health Study (CHS). METHODS: The frailty measure developed in CHS was delineated in the WHAS data sets. Using latent class analysis, we evaluated whether criteria composing the measure aggregate into a syndrome. We verified the criterion validity of the measure by testing whether participants defined as frail were more likely than others to develop adverse geriatric outcomes or to die. RESULTS: The distributions of frailty in the WHAS and CHS were comparable. In latent class analyses, the measures demonstrated strong internal validity vis à vis stated theory characterizing frailty as a medical syndrome. In proportional hazards models, frail women had a higher risk of developing activities of daily living (ADL) and/or instrumental ADL disability, institutionalization, and death, independently of multiple potentially confounding factors. CONCLUSIONS: The findings of this study are consistent with the widely held theory that conceptualizes frailty as a syndrome. The frailty definition developed in the CHS is applicable across diverse population samples and identifies a profile of high risk of multiple adverse outcomes.

Integrity signals

Registry

Crossref · 10.1093/gerona/61.3.262

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A transition to a greater level of frailty is more common than improvement.

    “a transition to a level of greater frailty is more common than improvement”

    From Frailty in elderly people (2013) · cites this paper as [93]

  • Frailty is a dynamic process.

    “Frailty is a dynamic process (93)”

    From Frailty in elderly people (2013) · cites this paper as [93]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bandeen-Roche, K., Xue, Q.-L., Ferrucci, L., Walston, J., Guralnik, J. M., Chaves, P., Zeger, S. L., & Fried, L. P.
Venue
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
Published
2006-03-01
Volume
61
Issue
3
Pages
262-266
ISSN
  • 1079-5006 (ISSN-L)
  • 1758-535X
OpenAlex
W2152456824
Cited by
1,215
References
30
Citations by year
2026: 31 · 2025: 36 · 2024: 67 · 2023: 43 · 2022: 60 · 2021: 64 · 2020: 80 · 2019: 89 · 2018: 62 · 2017: 77 · 2016: 86 · 2015: 75 · 2014: 82 · 2013: 77 · 2012: 65
FWCI
18.81
Type
journal article
Language
en
Open access
closed
Locations
  • The Journals of Gerontology Series A (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Johns Hopkins University
  • National Institutes of Health
  • National Institute on Aging (1R37AG199502, R01 AG11703, 1P50AG021334-01, R01AG011703)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
  • Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
frailty, Fried frailty phenotype, Women's Health and Aging Study, Cardiovascular Health Study, cross-validation, criterion validity, internal validity, activities of daily living disability, institutionalization, mortality, older women, aging
MeSH terms
Aged, Aging, Female, Humans, Phenotype, Geriatric Assessment, Frail Elderly, Women's Health

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review